Approval · Notice of Compliance 16453 · 2014
CLARITIN: Notice of Compliance 16453
Issued December 18, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16453
- Date
- December 18, 2014
- Company
- Bayer Inc Consumer CareMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Histamine H1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLARITIN | 00782696 | Marketed |
| CLARITIN KIDS | 02241523 | Marketed |
| CLARITIN RAPID DISSOLVE | 02380226 | Approved |
| CLARITIN RAPID DISSOLVE | 02237734 | Marketed |
Medicinal ingredients
- LORATADINE 10 MG per TAB
- LORATADINE 1 MG per ML
- LORATADINE 5 MG per TAB